Skip to content
DataLookout
Menu

NCT07913061

A Study Comparing SHR-3167 With Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal Insulin

StatusNot Yet Recruiting
PhasePhase 3
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Change in Glycated Hemoglobin A1c (HbA1c) (Non-inferiority)
Timeframe: From baseline to Week 26.

Secondary (2)

Hypoglycemia Event Rate during the treatment period
Adverse events (AEs)

Arms and interventions

SHR-3167 GroupExperimental

SHR-3167.

Insulin Degludec GroupActive comparator

Insulin degludec.

Drugs: SHR-3167, insulin degludec

Sites

2 sites in 1 country